Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-13

Clinical Trial Update: Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients [NA]

View source ↗

Summary

The trial from Fudan University evaluating hypofractionated partial-breast irradiation after breast-conserving surgery for low-risk breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | NA | Status: COMPLETED